Mexiletine shortens the QT interval in a pedigree of KCNH2 related long QT syndrome

J Arrhythm. 2020 Jan 8;36(1):193-196. doi: 10.1002/joa3.12300. eCollection 2020 Feb.

Abstract

A 23-year-old female had been suffering from recurrent syncopal episodes during sleep since her childhood. She had a family history of sudden death and her QTc interval was remarkably prolonged to 537 ms A Holter ECG revealed torsade de pointes, corresponding to syncope. She was started on mexiletine and her QTc interval shortened. Her symptoms were controlled after β-blockers and Ca-blockers were added. A genetic analysis with a next generation sequencer identified a frameshift mutation at the C terminus of the KCNH2 gene. Here we present a type 2 long QT syndrome case in which mexiletine was effective.

Keywords: KCNH2; long QT syndrome; mexiletine; sudden death; torsade de pointes.

Publication types

  • Case Reports